{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:00:30Z","timestamp":1785114030228,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ther Apher Dial"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cell\u2010free and concentrated ascites reinfusion therapy (CART) alleviates the symptoms of malignant ascites but may trigger inflammation. We investigated why AHF\u2010MO filter (A\u2010A)\u2013processed concentrates showed weaker bioactivity than EC20W filter (A\u2010E)\u2013processed concentrates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ascites from three patients with ovarian cancer were processed into untreated ascites (UA), A\u2010A, or A\u2010E. Whole ascites, extracellular vesicles (EVs), and EV\u2010depleted supernatants were injected intraperitoneally into mice. Serum cytokines were measured, and label\u2010free proteomics was used to identify inflammatory pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A\u2010E induced the strongest proinflammatory and Th17\/type I interferon responses compared to UA. A\u2010A produced intermediate activation. EV\u2010depleted A\u2010E supernatants remained highly bioactive. A\u2010E was enriched in proteins associated with cellular damage pathways and proinflammatory signaling. A\u2010A exhibited attenuated changes and preserved regulatory proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A\u2010A yields a more balanced inflammatory and proteomic profile than A\u2010E. Our findings provide a preliminary mechanistic rationale for its use in CART and offer targets for membrane optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/1744-9987.70201","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:52:56Z","timestamp":1785113576000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell Damage\u2013Like Proteomic Signatures Distinguish Cell\u2010Free and Concentrated Ascites Reinfusion Therapy (\n                    <scp>CART<\/scp>\n                    ) Membranes in Malignant Ascites: A Mechanistic Study"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6114-3007","authenticated-orcid":false,"given":"Masaki","family":"Nojima","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-8875","authenticated-orcid":false,"given":"Goh","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Urita","sequence":"additional","affiliation":[{"name":"Clinical Engineering Department Juntendo University Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-7133","authenticated-orcid":false,"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Life Sciences Kumamoto University  Kumamoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Juntendo University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-2760","authenticated-orcid":false,"given":"Akira","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitomo","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6880-4067","authenticated-orcid":false,"given":"Takumi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Kuga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-4765","authenticated-orcid":false,"given":"Makio","family":"Kusaoi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9126-3361","authenticated-orcid":false,"given":"Yasuhisa","family":"Terao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Juntendo University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4554-164X","authenticated-orcid":false,"given":"Atsuo","family":"Itakura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Juntendo University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-0840","authenticated-orcid":false,"given":"Kenichi","family":"Ikejima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-2954","authenticated-orcid":false,"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-1828","authenticated-orcid":false,"given":"Ken","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"issue":"5","key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0256-4947.55167","article-title":"Management of Ascites due to Gastrointestinal Malignancy","volume":"29","author":"Saif M. W.","year":"2009","journal-title":"Annals of Saudi Medicine"},{"issue":"4","key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the Challenge of Ascites in Ovarian Cancer: New Avenues for Therapy and Research","volume":"13","author":"Kipps E.","year":"2013","journal-title":"Nature Reviews. Cancer"},{"issue":"3","key":"e_1_2_8_4_1","first-page":"231","article-title":"The Management of Malignant Ascites and Impact on Quality of Life Outcomes in Women With Ovarian Cancer","volume":"1","author":"Meyer L.","year":"2016","journal-title":"Expert Review of Quality of Life in Cancer Care"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002480-197700230-00189","article-title":"Treatment of Intractable Ascites by Continuous Reinfusion of the Sterilized, Cell\u2010Free and Concentrated Ascitic Fluid","volume":"23","author":"Inoue N.","year":"1977","journal-title":"Transactions of the American Society for Artificial Internal Organs"},{"issue":"5","key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"e0177303","DOI":"10.1371\/journal.pone.0177303","article-title":"Safety and Efficacy of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy (CART) in Refractory Ascites: Post\u2010Marketing Surveillance Results","volume":"12","author":"Hanafusa N.","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1038\/s41598-019-46774-9","article-title":"Verification of Serum Albumin Elevating Effect of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy for Ascites Patients: A Retrospective Controlled Cohort Study","volume":"9","author":"Yamada Y.","year":"2019","journal-title":"Scientific Reports"},{"issue":"4","key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/jog.14670","article-title":"Quality of Life Assessment of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy During Initial Treatment for Advanced Ovarian Cancer: A Prospective Cohort Study","volume":"47","author":"Yamamoto K.","year":"2021","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"12","key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1007\/s00520-020-05401-4","article-title":"Safety and Efficacy of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy (CART) in Gastrointestinal Cancer Patients With Massive Ascites Treated With Systemic Chemotherapy","volume":"28","author":"Nagata Y.","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10147-014-0750-y","article-title":"Effects of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy (CART) on Symptom Relief of Malignancy\u2010Related Ascites","volume":"20","author":"Ito T.","year":"2015","journal-title":"International Journal of Clinical Oncology"},{"issue":"1","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12885-022-09298-6","article-title":"Adverse Effects of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites: A Single\u2010Institute Experience","volume":"22","author":"Tsubokura M.","year":"2022","journal-title":"BMC Cancer"},{"key":"e_1_2_8_12_1","first-page":"5484976","article-title":"Identification of Candidate Biomarkers in Malignant Ascites From Patients With Hepatocellular Carcinoma by iTRAQ\u2010Based Quantitative Proteomic Analysis","volume":"2018","author":"Zhang J.","year":"2018","journal-title":"BioMed Research International"},{"issue":"9","key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1021\/acs.jproteome.6b00548","article-title":"Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides","volume":"15","author":"Miyamoto S.","year":"2016","journal-title":"Journal of Proteome Research"},{"issue":"5","key":"e_1_2_8_14_1","first-page":"566","article-title":"Profiling of Cytokines in Human Epithelial Ovarian Cancer Ascites","volume":"2","author":"Matte I.","year":"2012","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.tranon.2025.102568","article-title":"Malignant Ascites in Ovarian Cancer: New Advances and Translational Opportunities","volume":"62","author":"Boo K. H.","year":"2025","journal-title":"Translational Oncology"},{"issue":"4","key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/14789450.2016.1165613","article-title":"Extracellular Vesicles in Ovarian Cancer: Applications to Tumor Biology, Immunotherapy and Biomarker Discovery","volume":"13","author":"Nawaz M.","year":"2016","journal-title":"Expert Review of Proteomics"},{"issue":"11","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/CMAR.S210568","article-title":"Malignant Ascite\u2010Derived Extracellular Vesicles Inhibit T Cell Activity by Upregulating Siglec\u201010 Expression","volume":"29","author":"Li Y.","year":"2019","journal-title":"Cancer Management and Research"},{"issue":"1","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","article-title":"Extracellular Vesicles in Ovarian Cancer Chemoresistance, Metastasis, and Immune Evasion","volume":"13","author":"Tian W.","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"19","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJM198211043071910","article-title":"Immune Complexes in Cancer","volume":"307","author":"Theofilopoulos A. N.","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1373\/clinchem.2010.153122","article-title":"CA125 Immune Complexes in Ovarian Cancer Patients With Low CA125 Concentrations","volume":"56","author":"Cramer D. W.","year":"2010","journal-title":"Clinical Chemistry"},{"issue":"2","key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00430-022-00743-8","article-title":"Immune Complexes as Culprits of Immunopathology in Severe COVID\u201019","volume":"212","author":"Kolb P.","year":"2023","journal-title":"Medical Microbiology and Immunology"},{"issue":"4","key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1744-9987.70022","article-title":"Cell\u2010Free Concentrated Ascites Reinfusion Therapy Enables Removal of Extracellular Vesicles and Circulating Immune Complexes in Ascites","volume":"29","author":"Yamaji Y.","year":"2025","journal-title":"Therapeutic Apheresis and Dialysis"},{"issue":"8","key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1021\/acs.jproteome.4c00149","article-title":"Improving Proteomic Identification Using Narrow Isolation Windows With Zeno SWATH Data\u2010Independent Acquisition","volume":"23","author":"Gu K.","year":"2024","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA\u2010NN: Neural Networks and Interference Correction Enable Deep Proteome Coverage in High Throughput","volume":"17","author":"Demichev V.","year":"2020","journal-title":"Nature Methods"},{"issue":"14","key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF01875497","article-title":"Proteases and Antiproteases Related to the Coagulation System in Plasma and Ascites\u2009\u2013\u2009An Approach to Differentiate Between Malignant and Cirrhotic Ascites","volume":"65","author":"Sch\u00f6lmerich J.","year":"1987","journal-title":"Klinische Wochenschrift"},{"issue":"4","key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage\u2010Associated Molecular Patterns in Inflammatory Diseases","volume":"18","author":"Roh J. S.","year":"2018","journal-title":"Immune Network"},{"issue":"4","key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.febslet.2012.01.010","article-title":"Follistatin\u2010Related Protein\/Follistatin\u2010Like 1 Evokes an Innate Immune Response via CD14 and Toll\u2010Like Receptor 4","volume":"586","author":"Murakami K.","year":"2012","journal-title":"FEBS Letters"},{"issue":"4","key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1567-5769(01)00193-X","article-title":"Roles of Bradykinin in Vascular Permeability and Angiogenesis in Solid Tumor","volume":"2","author":"Ishihara K.","year":"2002","journal-title":"International Immunopharmacology"},{"issue":"1","key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/jth.15551","article-title":"Both Plasma Basic Carboxypeptidases, Carboxypeptidase B2 and Carboxypeptidase N, Regulate Vascular Leakage Activity in Mice","volume":"20","author":"Zhou Q.","year":"2022","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"26","key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1073\/pnas.1202588109","article-title":"Revised Mechanism of Complement Lectin\u2010Pathway Activation Revealing the Role of Serine Protease MASP\u20101 as the Exclusive Activator of MASP\u20102","volume":"109","author":"H\u00e9ja D.","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"48","key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"33481","DOI":"10.1074\/jbc.M114.593129","article-title":"Lectin Galactoside\u2010Binding Soluble 3 Binding Protein (LGALS3BP) is a Tumor\u2010Associated Immunomodulatory Ligand for CD33\u2010Related Siglecs","volume":"289","author":"L\u00e4ubli H.","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1371\/journal.ppat.0030120","article-title":"Serum Amyloid Paids Complement\u2010Mediated Immunity to \n                     Streptococcus pneumoniae","volume":"3","author":"Yuste J.","year":"2007","journal-title":"PLoS Pathogens"},{"issue":"10","key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum Amyloid P Component Prevents Proteolysis of the Amyloid Fibrils of Alzheimer Disease and Systemic Amyloidosis","volume":"92","author":"Tennent G. A.","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"e10575","DOI":"10.1002\/jbm4.10575","article-title":"Vitamin D and Skeletal Muscle: Current Concepts From Preclinical Studies","volume":"5","author":"Girgis C. M.","year":"2021","journal-title":"JBMR Plus"},{"issue":"2","key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10047-023-01402-2","article-title":"Occurrence of Fever in Cell\u2010Free and Concentrated Ascites Reinfusion Therapy Is Not Related to the Primary Disease or Nature of Ascites","volume":"27","author":"Fukunaga S.","year":"2024","journal-title":"Journal of Artificial Organs"},{"issue":"5","key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10147-024-02682-1","article-title":"Cytokine Dynamics and Quality of Life: Unraveling the Impact of Cell\u2010Free and Concentrated Ascites Reinfusion Therapy in Ovarian Cancer Patients","volume":"30","author":"Ito R.","year":"2025","journal-title":"International Journal of Clinical Oncology"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1744-9987.70201","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1744-9987.70201","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1744-9987.70201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:53:01Z","timestamp":1785113581000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1744-9987.70201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":35,"alternative-id":["10.1002\/1744-9987.70201"],"URL":"https:\/\/doi.org\/10.1002\/1744-9987.70201","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"2026-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1744-9987.70201"}}